Jamie Wallisch wants companies to recognize that they truly have leverage. “Manufacturers do have an important part to play, even though it seems so high up and far removed,” she says.

BioNTech acquired the Marburg facility in 2020 from Novartis AG, which had used it to produce complex biological medicines.

The pace of the growth is putting a premium on logistics capabilities, including distribution centers positioned to quickly reach U.S. customers.

Acquiring Roundup as part of the deal to take over Monsanto has embroiled Bayer in costly litigation over allegations the weedkiller causes cancer, a charge the company denies.

Lilly is looking to double its capacity to make drugs that mimic incretin, a hormone that gives the sensation of having eaten, by the end of the year.

CVS’s drugstore chain is coping with headwinds that include diminished concerns about the pandemic, which has translated into fewer visits for COVID-19 tests and vaccinations.

The country has so far relied almost solely on homegrown medicines and vaccines to shore up immunity and treat COVID patients.